Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Clinical trial NCT00853827 · COMPLETED
Trial details
- NCT number
- NCT00853827
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-01-01
- Enrollment
- 613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.